Javier Aspa

Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients

Jacobo Rogado, J.M. Sánchez-Torres, Nuria Romero-Laorden et al. · European Journal of Cancer · 2019 · 252 citations

Cancer Immunosurveillance, Autoimmune Disease, Medicine +13

Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio

José Curbelo, Sergio Luquero‐Bueno, José María Galván‐Román et al. · PLoS ONE · 2017 · 164 citations · Full text

Guidelines for the Treatment of Community-acquired Pneumonia

Rosario Menéndez, Antoni Torres, Rafael Zalacaín et al. · American Journal of Respiratory and Critical Care Medicine · 2005 · 156 citations · Full text

Reaching Stability in Community-Acquired Pneumonia: The Effects of the Severity of Disease, Treatment, and the Characteristics of Patients

Rosario Menéndez, Antoni Torres, Felipe Rodrı́guez de Castro et al. · Clinical Infectious Diseases · 2004 · 138 citations · Full text

Community-acquired pneumonia in the elderly: Spanish multicentre study

Rafael Zalacaín, Antoni Torres, Raquel Celis et al. · European Respiratory Journal · 2003 · 134 citations · Full text